Skip to content
OpenCapital
Get started

Kiora Pharmaceuticals, Inc. KPRX Q4 2025 Annual earnings

Reported March 25, 2026 · Before market open

EPS-$1.60Miss by $0.93
Revenue estimate$1.5M
EPS estimate-$0.67

Next report

Aug 7, 2026 (In 1 week)
EPS estimate-$0.47

Versus estimates

Diluted EPS

Q1 2026-$0.58In line
Q4 2025-$1.60Miss by $0.93
Q3 2025$0.01Beat by $0.73Q2 2025-$0.54Beat by $0.04Q1 2025-$0.52Beat by $0.25Q4 2024-$1.04Miss by $0.40

Ask the moment Kiora Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Kiora Pharmaceuticals, Inc. report Q4 2025 earnings?
Kiora Pharmaceuticals, Inc. (KPRX) reported Q4 2025 earnings on March 25, 2026 before market open.
What were Kiora Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?
Kiora Pharmaceuticals, Inc. reported eps of $-1.60 for Q4 2025.
Did Kiora Pharmaceuticals, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.67 by $0.93.
How did Kiora Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 53.8% from $-1.04.
Where can I find Kiora Pharmaceuticals, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001372514-26-000025) and the 10-K periodic report (0001372514-26-000024) directly on SEC EDGAR. The filing index links above go to sec.gov.